Clinical Trials Directory

Trials / Completed

CompletedNCT03873090

SBRT in 4 Fractions for Prostate Cancer

Phase I-II Study of High Dose SBRT in 4 Fractions for Intermediate Risk Prostate Cancer

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
33 (actual)
Sponsor
Istituto Clinico Humanitas · Academic / Other
Sex
Male
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

This is a prospective multicentric phase-I-II pilot feasibility study. The main objective is to study early and late side effects of hypofractionated accelerated RT for prostate cancer with FFF (Free Flattened Filter) beam. The schedule will be \[ 4 x 9.5 Gy = 38 Gy \] delivered in 5 alternative days.

Conditions

Interventions

TypeNameDescription
OTHERSBRThypofractionated accelerated RT for prostate cancer with FFF (Free Flattened Filter) beam. The schedule will be \[ 4 x 9.5 Gy = 38 Gy \] delivered in 5 alternative days, corresponding to an NTD2 between 95 and 119 Gy for an α/β estimate between 3 and 1.5 Gy.

Timeline

Start date
2013-06-12
Primary completion
2018-05-23
Completion
2018-05-23
First posted
2019-03-13
Last updated
2019-03-13

Source: ClinicalTrials.gov record NCT03873090. Inclusion in this directory is not an endorsement.